
Lupin Limited has informed the Exchange regarding a press release dated December 13, 2024, titled "Lupin Acquires 3 Trademarks from Boehringer Ingelheim to Strengthen Diabetes Portfolio".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated December 13, 2024, titled "Lupin Acquires 3 Trademarks from Boehringer Ingelheim to Strengthen Diabetes Portfolio".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin